Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
03/24/1999 | CN1211444A Chinese medicinal powder preparation for treating hepatocirrhosis |
03/24/1999 | CN1211422A Prescription for treating hepatitis and tuberculosis |
03/24/1999 | CN1042633C Alkoxy alkyl carbamates from imidazo (1,2-a) pyridines |
03/23/1999 | US5886177 Phosphate linked oligomers |
03/23/1999 | US5886143 Reagent including at least nine hexose residues connected in iteratively branched configuration, functional moiety capable of reacting with binding moiety, target moiety or active agent |
03/23/1999 | US5886054 Administering to a patient effective doses of scleroglucan and xanthane gum, in combination with electrolyte and preservative; saliva or tears substitute |
03/23/1999 | US5886020 3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease |
03/23/1999 | US5886009 Quinuclidine derivative as a substance P antagonist |
03/23/1999 | US5886004 Tetrahydrobetacarboline compounds |
03/23/1999 | US5886002 Use of rifaximin and of pharmaceutical compositions containing it in the treatment of the diarrhoea from cryptosporidiosis |
03/23/1999 | US5885800 DNA encoding tumor necrosis related receptor, TR4 |
03/23/1999 | US5885592 Methods and pharmaceutical compositions for oral delivery of molecular iodine |
03/23/1999 | US5885548 Diethylenetriaminepentaacetic acid derivatives, their complexes and complex salts, that contain an element of atomic numbers 20-32, 39-51 for use as contrast media and antidotes |
03/23/1999 | CA2247735A1 Novel 5-membered ring heterocycles, their preparation, their use and pharmaceutical preparations comprising them |
03/23/1999 | CA2052713C Delivery of agents |
03/23/1999 | CA2025858C Antihepatopathic composition |
03/23/1999 | CA2016181C Arylthiazolylimidazoles as 5ht3 antagonists |
03/18/1999 | WO1999013064A2 Viral infection of cells using viral vectors |
03/18/1999 | WO1999013055A1 Human sigma receptor |
03/18/1999 | WO1999012944A2 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE |
03/18/1999 | WO1999012933A2 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
03/18/1999 | WO1999012931A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
03/18/1999 | WO1999012930A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their prepa ration and their use as cyclooxygenase 2 (cox-2) inhibitors |
03/18/1999 | WO1999012926A1 Tetrahydro gamma-carbolines |
03/18/1999 | WO1999012925A1 5,11-DIHYDRODIBENZ[b,e][1,4]OXAZEPINE DERIVATIVES AND MEDICINAL COMPOSITION CONTAINING THE SAME |
03/18/1999 | WO1999012916A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation |
03/18/1999 | WO1999012915A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals |
03/18/1999 | WO1999012566A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
03/18/1999 | WO1999012559A1 Inhibition of apoptotis using prosaposin receptor agonists |
03/18/1999 | WO1999012544A1 Intranasal formulation containing scopolamine and method of treating motion sickness |
03/18/1999 | WO1999012542A1 8a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS |
03/18/1999 | WO1999012541A1 Plant proanthocyanidin extract effective at inhibiting adherence of bacteria with p-type fimbriae to surfaces |
03/18/1999 | WO1999012538A1 Liver fat accumulation inhibitory composition, food additive for liver fat accumulation inhibition, and method of inhibiting liver fat accumulation |
03/18/1999 | WO1998056909A3 Secreted proteins and polynucleotides encoding them |
03/18/1999 | CA2304262A1 5,11-dihydrodibenzo[b,e][i,4]oxazepine derivatives and pharmaceutical composition containing the same |
03/18/1999 | CA2304108A1 Inhibition of apoptotis using prosaposin receptor agonists |
03/18/1999 | CA2303479A1 Human sigma receptor |
03/18/1999 | CA2303440A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals |
03/18/1999 | CA2303249A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
03/18/1999 | CA2303176A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
03/18/1999 | CA2303152A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors |
03/18/1999 | CA2302752A1 Humanized antibodies to human gp39, compositions containing and therapeutic use thereof |
03/18/1999 | CA2302470A1 Synthetic divalent slex containing polylactosamines and methods for use |
03/18/1999 | CA2301807A1 Tetrahydro gamma-carbolines |
03/18/1999 | CA2296358A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation |
03/18/1999 | CA2247551A1 Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
03/17/1999 | EP0902013A1 Novel amidine derivatives, their preparation and their use as medicaments with LTB-4 antagonistic effect |
03/17/1999 | EP0901483A2 Benzofurans and benzopyrans as chronobiological agents |
03/17/1999 | EP0901474A1 Aryl pyrimidine derivatives |
03/17/1999 | EP0901374A1 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders |
03/17/1999 | EP0901371A1 Alteration of microbial populations in the gastrointestinal tract |
03/17/1999 | EP0799231B1 Spiroketal derivatives, compositions containing them and their use as therapeutic agents |
03/17/1999 | EP0728148B1 Improved immunogenic compositions against human gastrin 17 |
03/17/1999 | EP0688226B1 Protein preparation for the prevention and therapy of periodontitis or other bacterial pathologies of the oral cavity |
03/17/1999 | CN1211251A 1,4-dihydropyridine compounds as bradykinin antagonists |
03/17/1999 | CN1211247A Novel substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl) butyl) benzamides useful for treatment of allergic diseases |
03/17/1999 | CN1211246A Novel substituted N-methyl-N-(4-(1H-benzimidazol-2-yl-amino) piperidin-1-yl)-2-(aryl) butyl) benzamides useful for treatment of allergic diseases |
03/17/1999 | CN1211238A Benzimidazole derivatives |
03/17/1999 | CN1211194A Implantable acrylamide copolymer hydrogel for therapeutic uses |
03/17/1999 | CN1211190A Natural tea for taking off the effects of drink and process for production thereof |
03/17/1999 | CN1211189A Urogenital and intestinal disorder compositions comprising a substrance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor |
03/17/1999 | CN1211188A Urogenital and intestinal compositions |
03/17/1999 | CN1211185A Sulfate conjugates of ursodeoxychloric acid, and their beneficial use in inflammatory disorders and other applications |
03/17/1999 | CN1211166A Liquid oral compositions comprising a calcium compound and an acidulant |
03/16/1999 | US5883293 Conformationally constrained backbone cyclized peptide analogs |
03/16/1999 | US5883132 Multistage reaction of amidation, activation, coupling and hydrolysis |
03/16/1999 | US5883124 Administering phenylacetic acid derivative and retinoid to treat tumors |
03/16/1999 | US5883116 3-(2'-alkoxybenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease |
03/16/1999 | US5883113 Tyrosine kinase inhibitors; antiproliferative and anticarcinogenic agents; diabetes, arthritis, restenosis, atherosclerosis |
03/16/1999 | US5882656 Useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, paget's disease, malignant hypercalcemia, and |
03/16/1999 | CA2244232A1 Novel def |
03/16/1999 | CA2167570C Flavanolignan preparations with improved liberation and resorbability |
03/16/1999 | CA2167198C Benzylaminoquinuclidines |
03/16/1999 | CA2164689C Nk-1 receptor antagonists and 5ht3 receptor antagonists for the treatment of emesis |
03/16/1999 | CA2158108C Compositions containing sertraline and a 5-ht1d receptor agonist or antagonist |
03/16/1999 | CA2150709C Pyrazolopyrimidines |
03/16/1999 | CA2073226C Pyrazolopyrimidinone antianginal agents |
03/16/1999 | CA2058264C Dihydrobenzofuran carboxamides and process for their preparation |
03/16/1999 | CA1340444C Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents |
03/11/1999 | WO1999011649A2 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same |
03/11/1999 | WO1999011645A1 Poly(adp-ribose) polymerase ('parp') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
03/11/1999 | WO1999011637A1 Protease inhibitors |
03/11/1999 | WO1999011628A1 Alkoxy-substituted compounds, methods, and compositions for inhi biting parp activity |
03/11/1999 | WO1999011620A1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors |
03/11/1999 | WO1999011283A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase |
03/11/1999 | WO1999011278A1 Robinia pseudoacacia lectin and its uses |
03/11/1999 | WO1999011265A1 Transdermal therapeutic system containing the active substance scopolamine base |
03/11/1999 | WO1999011264A1 Il-8 receptor antagonists |
03/11/1999 | WO1999011258A1 Lymphocyte function antigen-1 antagonists |
03/11/1999 | WO1999011253A1 Il-8 receptor antagonists |
03/11/1999 | WO1998056360A3 Film-coated tablet for improved upper gastrointestinal tract safety |
03/11/1999 | WO1998055126A3 Use of anti-inflammatory steroids for the treatment of chronic inflammatory intestinal diseases |
03/11/1999 | WO1998052937A3 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase |
03/11/1999 | DE19738643A1 Transdermales therapeutisches System mit dem Wirkstoff Scopolaminbase Transdermal therapeutic system with the active ingredient scopolamine |
03/11/1999 | CA2302450A1 Il-8 receptor antagonists |
03/11/1999 | CA2302364A1 Il-8 receptor antagonists |
03/11/1999 | CA2302361A1 Protease inhibitors |
03/11/1999 | CA2302168A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase |
03/11/1999 | CA2301848A1 Robinia pseudoacacia lectin and its uses |
03/11/1999 | CA2294133A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |